This virtual, single-arm clinical trial will evaluate the effects of Seed Cycling Capsules on symptoms associated with premenstrual syndrome (PMS) and menstrual cycle characteristics. Forty female participants aged 18 to 45 years will use the study products daily for two menstrual cycles. Participants will complete questionnaires at baseline, at the end of their period during Cycle 1, and at the end of their period during Cycle 2.
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Menstrual Cramp Severity
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)
Change in Bloating Severity
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)
Change in Fatigue Severity
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)
Change in Hormonal Acne Severity
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)
Change in Mood Symptoms
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)
Change in Sleep Quality
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)
Change in Breast Tenderness Severity
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)
Change in Libido
Timeframe: Day 28 (end of first 28-day intervention cycle), and Day 56 (end of second 28-day intervention cycle)